Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?

Amy Kunchok, Karl N. Krecke, Eoin P. Flanagan, Jiraporn Jitprapaikulsan, A. Sebastian Lopez-Chiriboga, John J. Chen, Brian G. Weinshenker, Sean J. Pittock

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Myelin oligodendrocyte glycoprotein-IgG is a biomarker associated with CNS demyelinating diseases.1,2 MOGAD and aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (AQP4-IgG + NMOSD) have overlapping clinical features including optic neuritis and myelitis. However, there are several clinical and radiologic distinguishing features of MOGAD including lack of female predominance, higher incidence of acute disseminated encephalomyelitis (ADEM), higher proportion of bilateral optic neuritis, and T2-signal confined to gray matter and conus involvement in myelitis.1,3,4

Original languageEnglish (US)
Pages (from-to)85-88
Number of pages4
JournalNeurology
Volume94
Issue number2
DOIs
StatePublished - Jan 14 2020

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?'. Together they form a unique fingerprint.

Cite this